Why it was recalled
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Product description
Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Lot numbers, UPCs & expiration codes
Lot #: a) MS1217, MS1218 , Exp.12/2017. Lot #: b) MS1215, Exp.12/2017 Lot #: c) MR11150, MR11151, MR11854, Exp. 10/2017; MR11798, MR11799, MS1214, Exp.11/2017
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1461-2016
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jul 19, 2016
- FDA report date
- Aug 24, 2016
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Zydus Pharmaceuticals USA Inc
Original FDA data
Every field from FDA enforcement report D-1461-2016, exactly as published.
Show all FDA fields
- City
- Pennington
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 74753
- Address
- 73 Route 31 N
- Code information
- Lot #: a) MS1217, MS1218 , Exp.12/2017. Lot #: b) MS1215, Exp.12/2017 Lot #: c) MR11150, MR11151, MR11854, Exp. 10/2017; MR11798, MR11799, MS1214, Exp.11/2017
- Postal code
- 08534-3601
- Report date
- Aug 24, 2016
- Product type
- Drugs
- Recall number
- D-1461-2016
- Classification
- Class II
- Recalling firm
- Zydus Pharmaceuticals USA Inc
- Termination date
- Sep 21, 2020
- Reason for recall
- Failed Dissolution Specifications: out of specification dissolution results in retained samples
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
- Distribution pattern
- Nationwide
- Recall initiation date
- Jul 19, 2016
- Initial firm notification
- Letter
- Center classification date
- Aug 18, 2016